These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 15084347)
1. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay. Roy P; Salminen H; Koskimies P; Simola J; Smeds A; Saukko P; Huhtaniemi IT J Steroid Biochem Mol Biol; 2004 Feb; 88(2):157-66. PubMed ID: 15084347 [TBL] [Abstract][Full Text] [Related]
2. Determination of androgen bioactivity in human serum samples using a recombinant cell based in vitro bioassay. Roy P; Franks S; Read M; Huhtaniemi IT J Steroid Biochem Mol Biol; 2006 Sep; 101(1):68-77. PubMed ID: 16893644 [TBL] [Abstract][Full Text] [Related]
3. Screening for (anti)androgenic properties using a standard operation protocol based on the human stably transfected androgen sensitive PALM cell line. First steps towards validation. Freyberger A; Witters H; Weimer M; Lofink W; Berckmans P; Ahr HJ Reprod Toxicol; 2010 Aug; 30(1):9-17. PubMed ID: 19836445 [TBL] [Abstract][Full Text] [Related]
4. Sensitive in vitro test systems to determine androgenic/antiandrogenic activity. Guth SE; Böhm S; Mussler BH; Eisenbrand G Mol Nutr Food Res; 2004 Sep; 48(4):282-91. PubMed ID: 15497179 [TBL] [Abstract][Full Text] [Related]
5. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189 [TBL] [Abstract][Full Text] [Related]
6. A new recombinant cell-based bioluminescent assay for sensitive androgen-like compound detection. Michelini E; Leskinen P; Virta M; Karp M; Roda A Biosens Bioelectron; 2005 May; 20(11):2261-7. PubMed ID: 15797324 [TBL] [Abstract][Full Text] [Related]
7. Screening of some anti-progestin endocrine disruptors using a recombinant yeast based in vitro bioassay. Chatterjee S; Kumar V; Majumder CB; Roy P Toxicol In Vitro; 2008 Apr; 22(3):788-98. PubMed ID: 18262749 [TBL] [Abstract][Full Text] [Related]
8. Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor. Blankvoort BM; de Groene EM; van Meeteren-Kreikamp AP; Witkamp RF; Rodenburg RJ; Aarts JM Anal Biochem; 2001 Nov; 298(1):93-102. PubMed ID: 11673900 [TBL] [Abstract][Full Text] [Related]
9. Detection of potential (anti)progestagenic endocrine disruptors using a recombinant human progesterone receptor binding and transactivation assay. Viswanath G; Halder S; Divya G; Majumder CB; Roy P Mol Cell Endocrinol; 2008 Nov; 295(1-2):1-9. PubMed ID: 18801410 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor activities of p,p'-DDE, fenvalerate and phoxim detected by androgen receptor reporter gene assay. Xu LC; Sun H; Chen JF; Bian Q; Song L; Wang XR Toxicol Lett; 2006 Jan; 160(2):151-7. PubMed ID: 16125883 [TBL] [Abstract][Full Text] [Related]
11. Human reporter gene assays: transcriptional activity of the androgen receptor is modulated by the cellular environment and promoter context. Simon S; Mueller SO Toxicology; 2006 Mar; 220(2-3):90-103. PubMed ID: 16413649 [TBL] [Abstract][Full Text] [Related]
12. Recombinant cell bioassays for endocrine disruptors: development of a stably transfected human ovarian cell line for the detection of estrogenic and anti-estrogenic chemicals. Rogers JM; Denison MS In Vitr Mol Toxicol; 2000; 13(1):67-82. PubMed ID: 10900408 [TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. Sonneveld E; Riteco JA; Jansen HJ; Pieterse B; Brouwer A; Schoonen WG; van der Burg B Toxicol Sci; 2006 Jan; 89(1):173-87. PubMed ID: 16221957 [TBL] [Abstract][Full Text] [Related]
14. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Wilson VS; Bobseine K; Lambright CR; Gray LE Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974 [TBL] [Abstract][Full Text] [Related]
15. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds. van der Burg B; Winter R; Man HY; Vangenechten C; Berckmans P; Weimer M; Witters H; van der Linden S Reprod Toxicol; 2010 Aug; 30(1):18-24. PubMed ID: 20438827 [TBL] [Abstract][Full Text] [Related]
16. Antiandrogenic activity of norgestimate in a human androgen-dependent stable-transfected cell line. Paris F; Rabeolina F; Balaguer P; Bacquet A; Sultan C Gynecol Endocrinol; 2007 Apr; 23(4):193-7. PubMed ID: 17505938 [TBL] [Abstract][Full Text] [Related]
17. Development of a stickleback kidney cell culture assay for the screening of androgenic and anti-androgenic endocrine disrupters. Jolly C; Katsiadaki I; Le Belle N; Mayer I; Dufour S Aquat Toxicol; 2006 Aug; 79(2):158-66. PubMed ID: 16843539 [TBL] [Abstract][Full Text] [Related]
18. Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals. Vinggaard AM; Joergensen EC; Larsen JC Toxicol Appl Pharmacol; 1999 Mar; 155(2):150-60. PubMed ID: 10053169 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the rodent Hershberger bioassay: testing of coded chemicals and supplementary molecular-biological and biochemical investigations. Freyberger A; Ellinger-Ziegelbauer H; Krötlinger F Toxicology; 2007 Sep; 239(1-2):77-88. PubMed ID: 17688994 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays. Akram ON; Bursill C; Desai R; Heather AK; Kazlauskas R; Handelsman DJ; Lambert G Anal Chem; 2011 Mar; 83(6):2065-74. PubMed ID: 21329390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]